Long-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis

With a growing number of disease-modifying therapies becoming available for relapsing multiple sclerosis, there is an important need to gather real-world evidence data regarding long-term treatment effectiveness and safety in unselected patient populations. Although not providing as high a level of...

Descripción completa

Detalles Bibliográficos
Autores principales: Druart, Charlotte, El Sankari, Souraya, van Pesch, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743180/
https://www.ncbi.nlm.nih.gov/pubmed/29317850
http://dx.doi.org/10.2147/PROM.S122401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743180/
https://www.ncbi.nlm.nih.gov/pubmed/29317850
http://dx.doi.org/10.2147/PROM.S122401

Ejemplares similares